Order intake and sales rose year-over-year, with adjusted EBIT margin slightly improved. Strong order backlog, record market cap, and stable equity support a positive outlook, with H2 2025 expected to outperform H1 and last year.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.